Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is rated as a Distinguished provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma.

Dr. Ronald Sweren is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous lymphoma/mycosis fungoides, phototherapy/ photopheresis and melanoma. Dr. Sweren also serves as director of the Phototherapy/Photopheresis Program in the Department of Dermatology. Dr. Sweren earned his M.D. from the University of Maryland School of Medicine. He completed his residency in dermatology at University of Maryland Medical Center and in pediatrics at Sinai Hospital of Baltimore. Dr. Sweren is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), Melanoma, and T-Cell Lymphoma.

Dr. Sima Rozati is an Assistant Professor of Dermatology at the Johns Hopkins University School of Medicine. She specializes in medical dermatology, cutaneous lymphoma, and supportive oncodermatology. She received her medical degree from the Shahid Beheshti University of Medical Sciences in Tehran. After completing her internal medicine residency at the Cleveland Clinic, she completed a research fellowship and PhD in cutaneous lymphoma at the University Hospital of Zürich in Switzerland. She returned to the U.S. where she completed cutaneous lymphoma fellowship, under the mentorship of Dr. Youn Kim, followed by dermatology residency at Stanford University School of Medicine in California. In a multidisciplinary environment, Dr. Rozati aims to provide excellent care to patients with cutaneous lymphoma and cancer whom are experiencing cutaneous adverse events from targeted therapies, immune- and chemotherapies. Dr. Rozati’s research interest focuses on cutaneous lymphoma, understanding the biology of this heterogeneous group of malignancies by analyzing the mutational and epigenetic landscape. Her translational research efforts is directed to investigate novel targeted and immunotherapeutic for cutaneous T cell lymphoma. She is a member of different professional organizations, including the American Academy of Dermatology and Woman’s dermatologic Society. Dr. Rozati is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. Her top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Localized Scleroderma.

Dr. Jihad Mohamad Alhariri is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatology and medical dermatology. Dr. Alhariri received his undergraduate degree from the American University of Beirut. He earned his M.D. from the American University of Beirut and his M.P.H. from the Johns Hopkins University School of Public Health. He completed a residency in internal medicine at Good Samaritan Hospital of Maryland and a residency in dermatology at Johns Hopkins. Dr. Alhariri is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Melanoma, Hidradenitis Suppurativa, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus.

Jun Kang is a Dermatologist in Baltimore, Maryland. Dr. Kang is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Dermatomyositis, Cutaneous Lupus Erythematosus (CLE), Discoid Lupus Erythematosus (DLE), and Localized Scleroderma.

Dr. Antony Rosen was an Osler resident and rheumatology fellow at Johns Hopkins Hospital before joining the faculty at Johns Hopkins, where he was appointed a professor in 2002. He served as director of the Division of Rheumatology between 2002 and 2022, overseeing a substantial expansion in the fellowship program and building the faculty from 14 to 26, and has been the Vice Dean for Research since 2013. Dr. Rosen received his medical degree from the University of Cape Town in South Africa in 1984 with first-class honors. After completing his internship in medicine & surgery and a year of postdoctoral study in medical biochemistry, he joined Dr. Alan Aderem at the Rockefeller University to pursue postdoctoral studies in immunology and cellular biology. Dr. Rosen is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Dermatomyositis, Polymyositis, Scleroderma, and Systemic Sclerosis (SSc).

Dr. Grant Anhalt is a professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include autoimmune skin diseases and dermatoimmunology. Dr. Anhalt serves as the director of the Dermatoimmunology Laboratory at the Johns Hopkins School of Medicine. He received his undergraduate degree and his M.D. from the University of Manitoba. He completed a residency in internal medicine at the Health Sciences Center in Winnipeg, Canada and a residency in dermatology at the University of Michigan. He performed a fellowship in immunodermatology at the University of Michigan Medical Center. Dr. Anhalt joined the Johns Hopkins faculty in 1982. He was interim chair of the Department of Dermatology from 1996 to 2001. His research interests include autoimmunity, bullous skin diseases and pemphigus and pemphigoid. Dr. Anhalt serves on the medical advisory board for the International Pemphigus & Pemphigoid Foundation. He has been recognized as a top doctor in the Washington Post Magazine, Baltimore Magazine and Castle Connolly Guide. He is a member of several professional organizations, including the American Academy of Dermatology, American Dermatologic Association and American Society for Clinical Investigation. CV http://www.hopkinsmedicine.org/dermatology/our_experts/CV/Anhalt_CV_2014.docx. Dr. Anhalt is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Pemphigus Vulgaris, Pemphigus, Pemphigus Foliaceus, and Bullous Pemphigoid.

Mark Davino, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians Odenton. He received his medical degree from the University of Maryland School of Medicine, and also completed his residency in internal medicine & pediatrics at the University of Maryland Medical Center. Dr. Davino is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Localized Scleroderma, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Hypertension.

Dr. Allan Gelber is Professor of Medicine and Deputy Director for Education and Faculty Development in the Division of Rheumatology. He holds a joint appointment in the Department of Epidemiology at the Bloomberg School of Public Health and is Associate Faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research. Dr. Gelber is a graduate of the Johns Hopkins University School of Medicine and received both his MPH and PhD degrees (the latter in Clinical Investigation) at the Bloomberg School. He pursued internship and residency training in internal medicine at Duke University and then undertook his fellowship training in rheumatology at Johns Hopkins. Dr. Gelber has had an active role as an Educator in the Rheumatic Diseases. He previously served as Fellowship Program Director at Johns Hopkins from 2001-2011. Thereafter, he shifted his primary educational focus from rheumatology fellows to medical students, and to internal medicine housestaff on the Bayview and Johns Hopkins campuses. He directs the Musculoskeletal Section of the Genes-to-Society Course to the 2nd year medical school class. Currently, Dr. Gelber serves as Thayer Firm Faculty Leader of the Osler Medical Training Program. and among the Aliki Scholars at Johns Hopkins Bayview Medical Center. Dr. Gelber chairs the M.D. Admissions Committee at the School of Medicine. Dr. Gelber is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Gout, Arthritis, Scleroderma, Knee Replacement, and Endoscopy.

Dr. Joy Wan is an Assistant Professor of Dermatology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include pediatric dermatology and atopic dermatitis. Dr. Wan received her undergraduate degree in biochemical sciences from Harvard University and her M.D. from the University of Pennsylvania. She completed dermatology residency training at the University of Pennsylvania and pediatric dermatology fellowship at the Children’s Hospital of Philadelphia. She also pursued postdoctoral research training in clinical epidemiology at the University of Pennsylvania. Dr. Wan joined the Johns Hopkins faculty in 2021. In addition to her clinical practice, Dr. Wan leads an active research program focused on epidemiologic and patient-oriented investigations of pediatric skin diseases including eczema. Dr. Wan is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. Her top areas of expertise are Atopic Dermatitis, Infantile Digital Fibromatosis, PHACE Syndrome, and Psoriasis.

Douglas Lienesch is an Internal Medicine specialist and a Rheumatologist in Elkton, Maryland. Dr. Lienesch is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Sjogren Syndrome, Necrotizing Vasculitis, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, and IgG4-Related Disease.

Dr. Ami Shah is an Associate Professor of Medicine and Director of the Division of Rheumatology at the Johns Hopkins University School of Medicine. Dr. Shah also serves as the Co-Director of the Johns Hopkins Scleroderma Center. Her areas of clinical expertise include rheumatology, particularly scleroderma and Raynaud's phenomenon. She is a graduate of the Massachusetts Institute of Technology and Johns Hopkins University School of Medicine. She completed her internal medicine residency training at Stanford University Hospital & Clinics and rheumatology post-doctoral fellowship at Johns Hopkins. During her fellowship training, she earned her Master of Health Science in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Shah’s clinical practice is focused on the broad spectrum of patients with scleroderma and related disorders, and her expertise includes management of complications such as Raynaud’s phenomenon, digital ischemia, pulmonary hypertension, cardiac dysfunction, myopathy, aggressive skin disease and concomitant cancer. Dr. Shah teaches post-doctoral fellows in her clinic about the evaluation and management of scleroderma. Dr. Shah’s research program has focused on the interface between cancer and autoimmunity in scleroderma, myositis and the newly emerging area of immune-related adverse events due to immune checkpoint inhibitor therapy. In highly collaborative studies, her group has published seminal observations linking cancer with the development of autoimmunity in scleroderma, with implications for cancer screening strategies in this population and the potential to shed insight into the pathogenesis of paraneoplastic rheumatic disease. In addition to her work in cancer and autoimmunity, Dr. Shah has an active research program in other clinical and therapeutic aspects of scleroderma, including early detection of cardiopulmonary complications and improving outcome measures and therapeutics for Raynaud's phenomenon. Dr. Shah also directs rheumatology precision medicine initiatives through the Johns Hopkins Individualized Health (inHealth) Initiative. The division’s program seeks to harness technological resources for comprehensive data collection and harmonization, strengthen novel data analytic approaches including defining unique patient subgroups, and accelerate the incorporation of discoveries into the delivery of clinical care. Dr. Shah has been a recipient of the ACR Research and Education Foundation Clinical Investigator Fellowship Award. In 2018, her research contributions were recognized at the 5th Systemic Sclerosis World Congress with receipt of the Edith Busch Prize for Young Investigators. In 2020, she was honored to receive the prestigious Henry Kunkel Young Investigator Award from the American College of Rheumatology. She is a member of the American College of Rheumatology. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. Her top areas of expertise are Scleroderma, Scleroma, Systemic Sclerosis (SSc), and Scleredema.

"Dr. Elisabeth ""Betsy"" Richard is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include both general dermatology as well as medical dermatology, specializing in phototherapy and photomedicine. Dr. Richard received her undergraduate degree from Middlebury College in Vermont. She earned her medical degree from the University of Massachusetts Medical School. She completed an internship in internal medicine at Washington Hospital Center and a residency in dermatology at Johns Hopkins.". Dr. Richard is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. Her top areas of expertise are Psoriasis, Plaque Psoriasis, Mycosis Fungoides, and Vitiligo.

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Paik is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. Her top areas of expertise are Dermatomyositis, Polymyositis, Myositis, and Scleroderma.

Dr. Sewon Kang is the Noxell Professor and Chairman of the Department of Dermatology at the Johns Hopkins University School of Medicine and the Dermatologist-in-Chief of Johns Hopkins Hospital. He is also founder and co-Director of the Cutaneous Translational Research Program (CTReP) at Hopkins. A recipient of the Dermatology Foundation's Career Development Award, he has received other research awards and grants from the American Dermatological Association, the National Psoriasis Foundation and the National Institutes of Health (Roadmap T32, K24, and R01). His research focus has been in the areas of skin pharmacology and photomedicine. He is the Past President of the Photomedicine Society, and the American Acne and Rosacea Society. Dr. Kang is or has been on the Board of Directors of multiple organizations including, the Society for Investigative Dermatology, the Association of Professors of Dermatology, the Dermatology Foundation, and the Skin of Color Society. An author on over 240 publications and book chapters, Dr. Kang is also the Editor-in-Chief of the 9th edition of the Fitzpatrick's Dermatology textbook. He is an inventor/co-inventor of 17 patents and has given over 300 presentations globally. A graduate with honors from Williams College and the University of Michigan, Dr. Kang completed dermatology residency and fellowship at the Harvard Medical School/Massachusetts General Hospital. He sees patients exclusively at the Johns Hopkins Hospital, and his areas of clinical expertise include photomedicine, skin cancer (melanoma), skin aging, and dermatology for ethnic skin. Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Melanoma, Acne, Prurigo Nodularis, and Rosacea.

Alan Matsumoto is a Rheumatologist in Wheaton-Glenmont, Maryland. Dr. Matsumoto is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Rheumatoid Arthritis (RA), Osteoporosis, Postmenopausal Osteoporosis, and Juvenile Primary Osteoporosis.

Howard Hauptman is a Rheumatologist in Baltimore, Maryland. Dr. Hauptman has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Sjogren Syndrome, and Polymyalgia Rheumatica. Dr. Hauptman is currently accepting new patients.

Michael Rudikoff is a primary care provider, practicing in Internal Medicine in Towson,, Maryland. Dr. Rudikoff is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Gastroparesis.

Donald Thomas is a Rheumatologist in Greenbelt, Maryland. Dr. Thomas is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, and Osteoporosis. Dr. Thomas is currently accepting new patients.